Rigel appoints Michael P. Miller to board, effective Feb 1, 2026

RIGEL PHARMACEUTICALS INC

Michael P. Miller appointed to Rigel board effective Feb 1, 2026; term expires at 2027 annual meeting.
Miller will serve on Compensation Committee; receives $50k annual retainer plus $10k for committee.
Initial option grant of 12,000 shares under 2018 Plan; annual grants of 3,000 options + 2,500 RSUs thereafter.
Board determined Miller is independent under applicable standards; no family relationships or transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.